Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.67 USD -7.73% Market Closed
Market Cap: 21.2m USD

Collplant Biotechnologies Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Collplant Biotechnologies Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$2.5m
CAGR 3-Years
64%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Revenue
$174.8m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
10%
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$96.5m
CAGR 3-Years
16%
CAGR 5-Years
91%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$124k
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Revenue
$1.3m
CAGR 3-Years
60%
CAGR 5-Years
125%
CAGR 10-Years
13%
M
Matricelf Ltd
TASE:MTLF
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
21.3m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
7.73 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Revenue?
Revenue
2.5m USD

Based on the financial report for Sep 30, 2025, Collplant Biotechnologies Ltd's Revenue amounts to 2.5m USD.

What is Collplant Biotechnologies Ltd's Revenue growth rate?
Revenue CAGR 5Y
-16%

Over the last year, the Revenue growth was 281%. The average annual Revenue growth rates for Collplant Biotechnologies Ltd have been 64% over the past three years , -16% over the past five years .

Back to Top